SBE’s mission is to maximize the chance of success of therapeutic drug candidates through their lifecycle inflection point (Phase II) by aligning the most compelling clinical programs with the most talented drug developers. We follow the science, work efficiently, and take smart risks to develop new medicines for pressing unmet medical needs.

SBE is a trusted development partner to biotechnology and pharmaceutical companies because we understand drug development risk better than anyone.